RecruitingOBSERVATIONAL

German Stroke Registry - Endovascular Treatment

This study, called the German Stroke Registry, is observing people in Germany who have had a type of stroke caused by a blocked blood vessel in the brain. Doctors are collecting information about how these patients are treated, specifically with an advanced procedure to unblock the vessel. They want to see how patients recover during their hospital stay and for up to 90 days after their stroke. This information includes details about the stroke itself, the treatment given, how well it works, any problems, and how the patient is doing afterwards. The goal is to better understand this treatment and improve care for future stroke patients.

At a glance

Status

Recruiting

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrolment target

10,000

Start

01 Jun 2015

Estimated completion

01 Jun 2027

Acute Ischemic Stroke

What is this study about?

This study, called the German Stroke Registry Endovascular Treatment, is an important project happening in Germany. Doctors and researchers are carefully watching and collecting information from people who have experienced a very serious type of stroke where a blood clot blocks a major artery in the brain. The treatment they are focusing on is called 'endovascular treatment,' which is a procedure to remove the clot or open the blocked vessel.

The main idea behind this study is to gather real-world information about how these patients are treated and how they recover. Doctors will collect details from the patient's routine medical care, including how well the treatment works, if there are any problems, and what their recovery looks like over time. They specifically look at how patients are doing during their hospital stay and for three months (90 days) after their stroke.

By gathering all this information from many different hospitals, the study hopes to get a clearer picture of how effective this advanced stroke treatment is. This helps healthcare professionals understand what works best, identify any common issues, and ultimately improve the care for people who suffer from this type of stroke in the future.

Key takeaways

This study collects information on how stroke patients are treated and recover.
It focuses on a specific treatment for blocked blood vessels in the brain.
You would receive standard medical care; no extra tests or treatments.
Data is collected for up to 90 days after a stroke.
The aim is to improve future stroke care.

Who may be eligible?

To be included in this study, you would need to have had a specific type of stroke called an acute ischaemic stroke. This means a blood clot blocked a blood vessel in your brain. You would also need to have received, or be suitable for, a clot-busting medicine (intravenous thrombolysis) within 4.5 hours of your stroke starting.

Importantly, scans must have confirmed that a major blood vessel in your brain is blocked and that this blockage matches your symptoms. You must also be over 18 years old.

There are no specific reasons listed that would prevent someone from joining the study, other than not meeting the above criteria.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Did you have a stroke caused by a blood clot?
Were you treated (or suitable for treatment) with clot-busting medicine within 4.5 hours?
Did scans show a major blood vessel in your brain was blocked?
Are you over 18 years old?

Answer every question to see your result.

What does participation involve?

If you participate in this study, you wouldn't need to do anything differently than your normal medical care. You would receive the standard treatment for your stroke as recommended by your doctors. The study itself doesn't involve any extra tests, medications, or visits beyond what your medical team would already plan for you.

Instead, the study involves your doctors collecting information from your routine medical records during your hospital stay and for up to 90 days (about 3 months) after your stroke. This might include details about your symptoms when you arrived at the hospital, your treatment, how well you recovered, and any medical problems that occurred. The total duration of your participation, in terms of data being collected, would be up to 90 days from the day your stroke started.

Potential risks and benefits

Since this study only involves collecting information from your routine medical care and doesn't ask you to undergo any extra procedures or treatments, there are no additional direct risks to you. You would be receiving the standard care for your stroke. The potential benefit is that the information gathered from your experience, along with many other patients, could help doctors better understand stroke treatment and improve care for future patients. You have the right to withdraw your consent for your data to be used in the study at any time without it affecting your medical care.

Locations (1)

University Medical Center Hamburg-Eppendorf (UKE)
Verified postcode
Hamburg, Germany· Recruiting

Common questions

What is an ischaemic stroke?

An ischaemic stroke happens when a blood clot blocks the blood supply to part of your brain, causing damage.

What is 'endovascular treatment'?

It's a medical procedure where doctors use special tools inserted through a blood vessel to remove a clot or open a blocked artery in the brain.

Will I get extra medicine or tests if I am in this study?

No, this study only collects information from the standard medical care you would receive anyway. You won't get any extra treatments or tests just for being in the study.

How long will my information be part of the study?

Information will be collected from your medical records during your hospital stay and for up to 90 days (about three months) after your stroke.

Will my personal details be shared?

The study aims to protect your privacy. Your information will be handled carefully, usually by removing direct identifiers, so individual patients cannot be easily identified.

How to find out more

Maximilian Schell

m.schell@uke.de +49 (0)1522/2834807 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.